Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Straumann Holding AG's gross profit for the
six
months ended in Jun. 2026 was €1,078 Mil. Straumann Holding AG's gross profit for the trailing twelve months (TTM) ended in Jun. 2026 was €1,955 Mil.
Straumann Holding AG (MIL:1STMN) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Straumann Holding AG had a gross margin of 71.96% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Straumann Holding AG Gross Profit Related Terms
Straumann Holding AG Gross Profit Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1STMN vs ISRG, BDX, MDLN: Gross Profit Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Gross Profit distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1,955 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Straumann Holding AG (MIL:1STMN) has a Gross Profit of €1,955 Mil as of Jun. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Straumann Holding AG and its competitors.
Is Straumann Holding AG's Gross Profit too high?
Straumann Holding AG's current Gross Profit is €1,955 Mil. Overall, Straumann Holding AG has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Gross Profit compare to ISRG and BDX?
Straumann Holding AG's Gross Profit of €1,955 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Straumann Holding AG and its competitors. Straumann Holding AG's current Gross Profit is €1,955 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (MIL:1STMN) is currently considered Significantly Undervalued. The stock's GF Value™ is €150.11, compared to a current price of €90.00 — trading 40% below its estimated fair value. The current Gross Profit is €1,955 Mil. Straumann Holding AG's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Straumann Holding AG (MIL:1STMN), the current Gross Profit is €1,955 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (MIL:1STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of €90.00 is trading 40% below its estimated GF Value™ of €150.11.
GuruFocus considers Straumann Holding AG to be Significantly Undervalued.
Key valuation signals for MIL:1STMN:
Gross Profit: €1,955 Mil
GF Value™: €150.11 vs. price of €90.00 (40% below fair value)
No single metric tells the full story. See the MIL:1STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
70GF Score
Get the complete analysis for MIL:1STMN
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1STMN has been successfully added to your 
